Iovance Biotherapeutics Inc (NAS:IOVA)
$ 9.4 0.28 (3.07%) Market Cap: 2.86 Bil Enterprise Value: 2.55 Bil PE Ratio: 0 PB Ratio: 3.70 GF Score: 39/100

Q2 2020 Iovance Biotherapeutics Inc Earnings Call Transcript

Aug 06, 2020 / 08:30PM GMT
Release Date Price: $31.15 (+0.94%)
Operator

Good afternoon, and welcome to the Iovance Second Quarter 2020 Financial Results Conference Call. (Operator Instructions)

Now I would like to turn the call over to Sara Pellegrino, Vice President, Investor and Public Relations at Iovance. Please go ahead.

Sara Pellegrino
Iovance Biotherapeutics, Inc. - VP of IR & Public Relations

Thank you, operator. Good afternoon, and thank you for joining us. Speaking on today's call, we have Maria Fardis, our President and Chief Executive Officer; Friedrich Finckenstein, our Chief Medical Officer; and Michael Swartzburg, Vice President of Finance and Principal Accounting Officer. This afternoon, we issued a press release that can be found on our website at iovance.com, which includes the financial results for the second quarter and first half ended on June 30, 2020, as well as corporate updates.

Before we start, I would like to remind everyone that statements made during this conference call will include forward-looking statements regarding Iovance's goals, business focus, business plan,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot